Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro. (Q54117845)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 February 2018
edit
Language Label Description Also known as
English
Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro.
scientific article published on 27 February 2018

    Statements

    Lenalidomide improvement of cisplatin antitumor efficacy on triple-negative breast cancer cells in vitro. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit